Breaking: Lilly Partners With US Firms to Make Mounjaro, Boost FDA approved Tirzepatide manufacturer Supply Eli Lilly, now the world's most valuable healthcare company by market capitalization, has seen its shares soar 62.5% this year due to high demand for their diabetes drug Mounjaro. The company plans to invest $5.3 billion to expand product